CD8A and neoplasm: For instance, both CD4+ as well as CD8+ T cells upon encounter with melanoma tumor cells, capture NKG2D (natural killer group 2, member D) and NKp46 (natural killer cell receptor 46) ligands by trogocytosis from the tumor cells.